SEARCH

SEARCH BY CITATION

References

  • 1
    Huggins C, Stevens RE, Hodges CL. Studies on prostatic cancer. II. The effect of castration on clinical patients with carcinoma of the prostate. Arch. Surg. 1941; 43: 209.
  • 2
    Huggins C & Hodges CV. Studies on prostatic cancer; effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941; 1: 293 7.
  • 3
    Sinha AA, Blackard CE, Seal US. A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma. Cancer 1977; 40: 2836 50.
  • 4
    Emmett JL, Greene LF, Papantoniou A. Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies. J. Urol. 1960; 83: 471 84.
  • 5
    Raghavan D. Non-hormone chemotherapy for prostate cancer: Principles of treatment and application to the testing of new drugs. Semin. Oncol. 1988; 15: 371 89.
  • 6
    Kres W. Current chemotherapy and future directions in research for the treatment of advanced hormone- refractory prostate cancer. Cancer Invest. 1995; 13: 296 312.
  • 7
    Buttyan R, Zaker Z, Lockshin R, Wolgemuth D. Cascade induction of c-fos, c-myc and heat shock 70K transcripts during regression of the rat vetral prostate gland. Mol. Endcrinol. 1988; 2: 650 7.
  • 8
    Colombel M, Radvanyi F, Blanche M et al. Androgen suppressed apoptosis is modified in p53 deficient mice. Oncogene 1995; 10: 1269 74.
  • 9
    Brooks JD, Bova GS, Ewing CM et al. An uncertain role for p53 gene alterations in human prostate cancers. Cancer Res. 1996; 56: 3814 22.
  • 10
    Sinha BK, Yamazaki H, Eliot HM, Schneider E, Borner MM, O’Connor PM. Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells. Biochem. Biophys. Acta 1995; 1270: 12 18.
  • 11
    Berchem. GJ, Bosseler M, Sugars LVY, Voeller HJ, Zeitlin S, Gelmann EP. Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells. Cancer Res. 1995; 55: 735 8.
  • 12
    McDonnell TJ, Troncoso P, Brisbay SM et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992; 52: 6940 4.
  • 13
    Colombel M, Symmans F, Gil S et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancer. Am. J. Pathol. 1993; 143: 390 400.
  • 14
    Arends MJ, Morris RG, Wyllie AH. Apoptosis: The role of the endonuclease. Am. J. Pathol. 1990; 136: 593 608.
  • 15
    Wyllie AH. Apoptosis (The 1992 Frank Rose Memorial lecture). Br. J. Cancer 1993; 67: 205–8.
  • 16
    Borzillo GV, Endo K, Tsujimoto Y. Bcl-2 confers growth and survival advantage to interleukin 7- dependent early pre-B cells which become factor independent by a multistep process in culture. Oncogene 1992; 7: 869 76.
  • 17
    Kauffmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, campthecin, and other cytotoxic anticancer drugs: A cautionary note. Cancer Res. 1989; 49: 5870 8.
  • 18
    Raffo AJ, Perlman H, Chen M-W, Day ML, Streitmean JS, Buttyan R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 1995; 55: 4438 45.
  • 19
    Kerr JFR, Winterford CM, Harmon BV. Apoptosis: Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013 26.
  • 20
    McConkey DJ, Green G, Pettaway CA. Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. Cancer Res. 1996; 56: 5594 9.
  • 21
    Manning FCR & Patierno SR. Apoptosis: Inhibitor or instigator of carcinogenesis? Cancer Invest. 1996; 14: 455 65.
  • 22
    Weidner N, Carrol PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 1993; 143: 401 3.
  • 23
    Bigler SA, Brawer MK, Deering RE. Comparison of microscopic vascularity in benign and malignant prostatic tissue. Human Pathol. 1993; 24: 220 6.
  • 24
    Wakui S, Furusato M, Itoh T et al. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study. J. Pathol. 1992; 168: 257 62.
  • 25
    Furusato M, Wakui S, Sasaki H, Itoh T, Ushigome S. Tumor angiogenesis in latent prostatic carcinoma. Br. J. Cancer 1994; 70: 1244 6.
  • 26
    Polverini PJ. Macrophage induced angiogenesis: A review. Cytokines 1989; 1: 54 73.